Skip to content

Author

Ryuta Tabata

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

Several study designs for identifying optimal biological dose (OBD) have been proposed for phase I, II, and I/II clinical trials, considering toxicity and efficacy of anticancer drugs, especially molecular‐targeted therapies and immune checkpoint inhibitors. Among these, the multiple‐dose randomized phase II trial (MER...

Ryuta Tabata, Tomohiro Ohigashi, Takashi Sozu · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.